Starbucks is partnering with Ariana Grande on its latest coffee offering. The coffee chain and singer both posted twin cloud emoji tweets on Monday. Grande tagged @Starbucks, leading fans online to piece together that she was teasing the new "Cloud Macchiato," which Starbucks ($SBUX) officially launched this week. She followed those up with a pair of new tweets Tuesday morning showing the singer decked out in a Starbucks apron sipping on one of the new bevvies.
Internal documents showed that Grande was helping the company launch the new beverage, according to Business Insider.
Grande might already be considered an unofficial brand ambassador given how many times she's been snapped holding a Starbucks drink. Starbucks has not confirmed that it has a partnership with the "Thank U, Next" singer, though BI reported that as part of the promotion some stores will also feature Grande-approved playlists and songs.
The Cloud Macchiato is a twist on an Italian coffee staple. The "macchiato," literally translated to "stained" is a shot of espresso with a bit (stain) of frothed milk. Starbucks gained success bastardizing that and other Italian cafe classics with iced versions, caramel drizzles, and mocha. The Cloud version will come in cinnamon or caramel versions with a dollop of whipped cold milk foam, according to the press release.
Burger King is closing two dozens locations in the Detroit area and laying off 424 employees as it plans to permanently cease operations in Michigan. The Texas-based burger chain blamed "unforeseen business circumstances." The closures started on March 17 and are expected to be finished by April 15.
Minnesota Attorney General Keith Ellison is slated to lead off opening statements expected for Tuesday in his state's lawsuit against Juul Labs – marking the first time any of the thousands of cases against the e-cigarette maker over its alleged marketing to young people is going to play out in a courtroom.
Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report.
